Ignite Creation Date:
2024-05-05 @ 11:43 AM
Last Modification Date:
2024-10-26 @ 9:12 AM
Study NCT ID:
NCT00110981
Status:
COMPLETED
Last Update Posted:
2013-05-24
First Post:
2005-05-16
Brief Title:
Utilization of Narrow Band Ultraviolet B UVB Light Therapy and Etanercept for the Treatment of Psoriasis
Sponsor:
Amgen
Organization:
Amgen
Study Overview
Official Title:
A Multicenter Open-Label Pilot Trial to Evaluate the Effectiveness and Safety of ENBRELr in Combination With Narrowband UVB Phototherapy for the Treatment of Psoriasis
Status:
COMPLETED
Status Verified Date:
2013-05
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this study is to evaluate the safety and effectiveness of combination therapy with etanercept and narrow-band NB UVB phototherapy for the treatment of psoriasis in a pilot study This is a Phase 4 clinical study being conducted under an Amgen Investigational New Drug Application IND
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None